Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Toronto

$105,000.00

Modulation of a Candida albicans Virulence Trait by Lactobacillus-Secreted Beta-Carbolines

EF 2020-21

Résumé
In humans, the fungus Candida albicans naturally colonizes mucosal sites such as the mouth and vagina. As a member of the commensal microbial community, C. albicans is an opportunistic pathogen that can cause superficial infections in healthy people and life-threatening systemic disease in immunocompromised individuals. Approximately 75% of people with a vagina will experience vaginal candidiasis, commonly known as a yeast infection, at least once in their lifetime. Previous work demonstrated that a decrease in the abundance of commensal bacteria, due to factors including antibiotic treatment, allows for the overgrowth of fungi and the development of fungal infections. Current research is therefore focused on exploiting probiotic bacteria, such as Lactobacillus species, to promote a healthy vaginal microbiome and prevent the development of vaginal yeast infections. To identify the mechanism by which probiotics affect the ability of C. albicans to cause disease, I examined the effects of several Lactobacillus species on a key virulence trait in C. albicans. I observed that several species of Lactobacillus produce a factor that represses this virulence trait and may reduce the ability of C. albicans to cause disease. I identified and characterized this secreted factor, which was a single small molecule. Through selection-based experiments, I was then able to identify C. albicans mutants which are resistant to the effects of the molecule. Whole genome sequencing and follow-up genetic analyses identified a resistance-conferring mutation in a protein that regulates C. albicans virulence. Currently, I am characterizing the ability of this molecule to treat vaginal candidiasis using a mouse model of infection. Collectively, this research will provide a novel strategy to treat recurrent fungal infections that affect millions of people worldwide.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
439408
Name
MacAlpine Jessie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Modulation of a Candida albicans Virulence Trait by Lactobacillus-Secreted Beta-Carbolines
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Antimicrobial Development; Fungal Pathogens; Genetics; Infection And Immunity; Microbial Pathogenesis; Molecular Biology; Morphology; Polymicrobial Interactions
Abstract
In humans, the fungus Candida albicans naturally colonizes mucosal sites such as the mouth and vagina. As a member of the commensal microbial community, C. albicans is an opportunistic pathogen that can cause superficial infections in healthy people and life-threatening systemic disease in immunocompromised individuals. Approximately 75% of people with a vagina will experience vaginal candidiasis, commonly known as a yeast infection, at least once in their lifetime. Previous work demonstrated that a decrease in the abundance of commensal bacteria, due to factors including antibiotic treatment, allows for the overgrowth of fungi and the development of fungal infections. Current research is therefore focused on exploiting probiotic bacteria, such as Lactobacillus species, to promote a healthy vaginal microbiome and prevent the development of vaginal yeast infections. To identify the mechanism by which probiotics affect the ability of C. albicans to cause disease, I examined the effects of several Lactobacillus species on a key virulence trait in C. albicans. I observed that several species of Lactobacillus produce a factor that represses this virulence trait and may reduce the ability of C. albicans to cause disease. I identified and characterized this secreted factor, which was a single small molecule. Through selection-based experiments, I was then able to identify C. albicans mutants which are resistant to the effects of the molecule. Whole genome sequencing and follow-up genetic analyses identified a resistance-conferring mutation in a protein that regulates C. albicans virulence. Currently, I am characterizing the ability of this molecule to treat vaginal candidiasis using a mouse model of infection. Collectively, this research will provide a novel strategy to treat recurrent fungal infections that affect millions of people worldwide.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
MacAlpine, Jessie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~